CellSeed's Regenerative medicine technology
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
- IR FY 2020 Financial results will be announced on February 12th.
- Event Give a lecture "Translate! 2021 – Metrics and Milestones of Success"
- Others Added CellSeed Product / Service video list page
- IR Summary of Consolidated Financial Results for the Nine Months Ended September 30, 2020 (J-GAAP)
- Others Bridge Report the first half of the fiscal year ending December 2020